(Adds Outlook)
Looking ahead, GoodRx Holdings, Inc. (GDRX) expects a rise in first quarter and full-year revenue.
For the first quarter of 2025, GoodRx expects revenue of $201 to $205 million, in line with analysts' forecast of $202.58 million. For the same quater of the prior year, the company had recorded revenue of $197.9 million.
For the full-year 2025, GDRX anticipates adjusted EBITDA of $270 to $286 million, up from the $260.2 million of 2024.
GoodRx projects its annual revenue to be in the range of $810 to $840 million, in line with Street view of $825.6 million. For the full-year 2024, the company had recorded revenue of $792.3 million.
Q4 Results:
Below are the earnings highlights for GoodRx Holdings, Inc. (GDRX):
Earnings: $6.740 million in Q4 vs. -$25.869 million in the same period last year.
EPS: $0.02 in Q4 vs. -$0.06 in the same period last year.
Excluding items, GoodRx Holdings, Inc. reported adjusted earnings of $34.748 million or $0.09 per share for the period.
Analysts projected $0.1 per share
Revenue: $198.583 million in Q4 vs. $196.644 million in the same period last year.
For comments and feedback: editorial@rttnews.com